Integral Roles for Integrins in γδ T Cell Function

Integrins are adhesion receptors on the cell surface that enable cells to respond to their environment. Most integrins are heterodimers, comprising α and β type I transmembrane glycoprotein chains with large extracellular domains and short cytoplasmic tails. Integrins deliver signals through multiprotein complexes at the cell surface, which interact with cytoskeletal and signaling proteins to influence gene expression, cell proliferation, morphology, and migration. Integrin expression on γδ T cells (γδTc) has not been systematically investigated; however, reports in the literature dating back to the early 1990s reveal an understated role for integrins in γδTc function. Over the years, integrins have been investigated on resting and/or activated peripheral blood-derived polyclonal γδTc, γδTc clones, as well as γδ T intraepithelial lymphocytes. Differences in integrin expression have been found between αβ T cells (αβTc) and γδTc, as well as between Vδ1 and Vδ2 γδTc. While most studies have focused on human γδTc, research has also been carried out in mouse and bovine models. Roles attributed to γδTc integrins include adhesion, signaling, activation, migration, tissue localization, tissue retention, cell spreading, cytokine secretion, tumor infiltration, and involvement in tumor cell killing. This review attempts to encompass all reports of integrins expressed on γδTc published prior to December 2017, highlights areas warranting further investigation, and discusses the relevance of integrin expression for γδTc function.

Introduction

Although much was known about integrins on lymphocytes as early as 1990 (1), integrin expression on γδTc has been only sporadically, and often indirectly, investigated. Considered all together, these reports reveal an understated role for integrins in γδTc function (Table 1).

TABLE 1

Table 1. Integrin expression reported on γδ T cells; cells used were blood-derived unless otherwise indicated.

Integrins are heterodimeric adhesion receptors comprising non-covalently linked α and β chains (2). Greek letters indicating chain pairings for β1 and cluster of differentiation designations for β2 integrins are used throughout this review; cited works may have used alternative nomenclature.

Integrin Activation and Functions

Integrins play a role in many cellular functions including development, activation, differentiation, proliferation, mobility, and survival (1, 3). Integrins enable two-way communication between cells (cytoskeleton) and their surroundings [extracellular matrix (ECM), other cells]. ECM proteins with which integrins interact include collagen, a structural protein, and adhesion proteins fibronectin (FN) and vitronectin (4). Signaling through integrins can be “inside-out,” regulating extracellular interaction between integrins and their ligands, but also “outside-in,” influencing actin cytoskeleton rearrangement as well as gene expression and transcription of associated proteins, including cytokines, to impact cellular processes (5, 6).

Integrins are integral to lymphocyte homing to tissues and migration within tissues; they—together with selectins and their respective ligands—participate in tethering, rolling, and adhesion (7). Integrins respond to chemokine signaling arresting migration of lymphocytes and facilitating transmigration into tissues (8). In contrast to other cell types, β1 integrins on conventional T cells require activation for adhesion to occur (9, 10). Basal adhesion levels reflect inactive or low-affinity status of integrins; stimulus with 12-O-tetradecanoylphorbol-13-acetate, anti-CD3 or anti-CD2 activates β1 integrins, converting them to a high-affinity state without necessitating greater surface expression (10). Such activation dependence is also true for the β2 integrin CD11a/CD18 in T cell adhesion and de-adhesion (11). Indeed, several integrins serve as costimulatory molecules in concert with T cell antigen receptor (TCR) engagement (10, 12–14). Much occurs downstream of integrin-mediated cell adhesion, including phosphorylation of proteins in signaling pathways for cell cycle, cytokine expression, and cytoskeletal remodeling enabling processes such as proliferation and migration (3, 6).

Integrins on human γδTc will first be considered, loosely grouped according to function, and then findings in other species will be discussed. Figure 1 depicts integrins found on γδTc and some of their functions.

FIGURE 1

Figure 1. Integrins found on γδ T cells and some of their functions. Red stars indicate integrins whose expression and/or function on γδTc has been reported to require activation. Vitronectin receptor signals through CD3 zeta of the TCR.

Adhesion and Signaling

In 1992, α4, β1, and CD18 were identified on human Vγ9 γδTc derived from stimulated peripheral blood mononuclear cells (PBMCs). While no α3, αv, or β3 expression was observed, less than 30% expressed α1, α2, or α5 chains. CD8⁺ γδTc clones expressed high β1, and consistent α4 and α5 levels. Phorbol 12-myristate 13-acetate (PMA)-induced adhesion via integrin activation; while α2β1 was required for collagen binding, FN binding relied on both α4β1 and α5β1. Most polyclonal γδTc only expressed α4β1, whereas individual clones showed variation attributed to extended culturing and selection during cloning (15), corroborating evidence that β1 expression on T cells increases qualitatively and quantitatively over time in culture (1, 16). Admittedly, these studies used activated γδTc and may not have reflected the state of cells in circulation (15).

Expression of α4 and α5 on CD3⁺CD4⁻CD8⁻ γδTc, and lack of α3 or α6 was confirmed. Activated CD25^hi γδTc bound FN better than resting CD25^low γδTc, mediated mostly by α4 and partly by α5. Culturing cells on immobilized anti-γδ TCR antibodies together with FN enhanced proliferation and increased CD25 expression, suggesting both signaling and adhesion roles for α4 and α5 integrins. While γδTc adhesion required activation through the TCR, surface levels of α4 and α5 remained unaltered (17). Cytokines such as interleukin (IL)-1β and TNF-α may influence γδTc integrin expression and/or activation (18); this has yet to be explored.

Compared to αβTc, fresh primary γδTc were more adhesive (~2:1 to 4:1) to endothelial cells, fibroblasts, and epithelial cells independent of activation. Both αβTc and γδTc required CD11a/CD18 and α4β1 to bind endothelial cells, whereas CD11a/CD18-ICAM-1 interaction facilitated adherence to fibroblasts and epithelial cells. Phorbol dibutyrate treatment of PBMCs and cytokine stimulation of monolayers greatly enhanced T cell adhesion, correlated with their expression of CD11a/CD18 and α4β1 (9). CD11a, b, c, and CD18 were detected on isopentenyl pyrophosphate (IPP)-stimulated γδTc, in parallel with markers indicating antigen presenting potential; integrins were likely involved in clustering between γδTc and naïve αβTc in an activation capacity, but their role was not directly addressed (19). It would be of interest to determine whether loss of one or more integrins might impact γδTc antigen presentation.

In healthy women, constitutively high CD11c levels were observed on circulating CCR7⁻CD4⁻ populations co-expressing γδTCR and CD8; cervical γδTc (>20%) also expressed CD11c. α1β1 and α4β7 were co-expressed on CD11c⁺CCR7⁻CD4⁻ T cells, of which γδTc were a part, but unfortunately not specifically analyzed. CD11c expression was associated with T cell homing and activation, and interferon γ (IFNγ) secretion in a fraction of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-stimulated γδTc (20).

CD11d, first described in 1995 (21), has now been identified on both murine (22) and human γδTc (23). CD11d/CD18 binds vascular cell adhesion molecule (VCAM-)1 (24) and intercellular adhesion molecule (ICAM-)3 (21). Vδ1 clones cultured on anti-ICAM-3 plates in the presence of IL-2 underwent spreading; however, the participating receptor on γδTc had not yet been identified (25). Since ICAM-3 is a CD11d ligand, and CD11d is highly expressed on Vδ1 γδTc (23), it was likely CD11d-ICAM-3 interaction mediating this response. ICAM-3 may play a role in inflammatory response initiation, potentially aiding in such processes as antigen presentation and cytotoxicity (26). ICAM-3 on neutrophils participates in IFNγ production but not cytotoxicity of NK cells (27) and has some predictive value in perioperative systemic inflammatory response syndrome (28). Thus, CD11d on γδTc may play a role in inflammation, but this requires further investigation.

Transendothelial Migration

In the first report investigating mechanisms by which γδTc cross the endothelium to migrate into inflamed tissue from the circulation, CD11a/CD18 and α4β1 on γδTc bound to endothelial cell ligands CD54/ICAM-1 and VCAM-1, respectively, increasing endothelial cell permeability. While cytotoxicity of γδTc clones to endothelial cells surely contributed to endothelial layer permeability, it was thought unlikely to occur with autologous cells in vivo (29).

An immunophenotyping study showed that γδTc had greater transendothelial migratory capacity than αβTc (30), explaining γδTc enrichment in chronic inflammation (31, 32), attributed to CD11a/CD18 expression, and increased α4, α5, and α6 β1 integrin density on migrating compared to non-migrating T cells; blocking assays were not performed to confirm functional relevance here (30). While CD11d expression on PBMC-derived γδTc was higher compared to αβTc (freshly isolated or expanded), their migratory ability was not compared (23). In a non-human primate tuberculosis model, adoptively transferred Vδ2 cells trafficking to infected airways expressed CD11a/CD18 (33). In contrast, increased numbers of peripheral γδTc expressing reduced CD18 levels were identified in patients suffering acute psoriasis, suggesting a role in disease pathogenesis (34).

Integrins on Vδ1 Versus Vδ2 Directing Localization and Tissue Retention

Integrins likely play a role in the tissue specificity of γδTc subsets. In Galéa’s study, Vδ1 and Vδ2 migrated similarly, suggesting that Vδ1 tissue accumulation relates to their retention rather than migratory abilities (30). Indeed, higher CD11d expression on Vδ1 compared to Vδ2 cells may also account for preferential Vδ1 retention (23), as well as Vδ1 prevalence in large intestinal mucosal epithelium (35) and conditions such as rheumatoid arthritis (31, 32, 36).

An E-cadherin binding integrin associated with epithelial retention, αEβ7 (CD103), was found on human γδTc intraepithelial lymphocytes (IELs). While peripheral blood T cells did not express much αEβ7 the authors posited its upregulation after T cells extravasate in the lamina propria, since αEβ7 expression positively correlated with nearer proximity to epithelium (37). IL-2 and phytohemagglutinin (PHA) stimulation activated αEβ7 on cultured CD4⁺CD8⁺ IEL, and TCR crosslinking enhanced αEβ7-E-cadherin avidity (38). On αβTc, this transforming growth factor β (TGF-β)-induced integrin is associated with pro- and anti-inflammatory conditions, tissue retention, and both cytotoxic and regulatory T lymphocyte tumor infiltration and function, expertly reviewed in Ref. (39). Peters and colleagues noted upregulation of ITGAE, the gene encoding αEβ7, and corresponding surface expression on expanded Vδ2 cells treated with TGF-β and IL-15 correlating with enhanced proliferation and IL-9 production (40).

Subset variation exists for α5β1, with Vδ1 expressing more than Vδ2, providing an explanation for previous reports of low α5β1 expression in studies focusing on Vδ2 cells. High α5β1 expression accounted for increased Vδ1 binding to FN, potentially reflecting Vδ1 adhesion to fibroblasts in vivo, and the importance of this interaction for Vδ1 activation and localization (9). During inflammation, mucosal epithelial cells display increased FN levels (41), which may increase Vδ1 retention. Similar ICAM-1 and VCAM-1-mediated binding of Vδ1 and Vδ2 cells could be explained by their comparable expression of CD11a/CD18 and α4β1 (9). Thus, γδTc tissue recruitment may be achieved through CD11a/CD18 and α4β1 binding to endothelial cell ligands, and cells retained in tissue via CD11a/CD18 and α5β1 interactions with epithelial cell-, fibroblast-, and ECM ligands (9).

Tumor Infiltration

Increased α1β1 expression may facilitate γδTc migration out of vessels and infiltration into tumors (16). A known receptor for the basement membrane protein collagen IV, α1β1 has been observed on IL-2-activated T cells invading tumors (42–47). While resting peripheral blood T cells expressed little α1β1, its expression increased over time in culture; γδTc clones expressed higher α1β1 than polyclonal T cells (16), corroborating observed α1β1 expression on long-term activated T cells (48). Anti-α1β1 inhibited CD8⁺ γδTc interaction with collagen IV, but not FN or collagen I, in a concentration-dependent manner. Cellular morphology was impacted, as Mg²⁺ cation-dependent spreading of long-term cultured CD8⁺ α1β1^high αβTc or γδTc on collagen IV-coated slides was inhibited by anti-α1β1 antibodies (16).

Compared to αβTc, γδTc derived from patient blood bound squamous carcinoma (SCC) and fibroblast cells more tightly (49), confirming previous results (9). While CD11a/CD18 played a role in both cases, SCC binding was mediated via l-selectin and CD44v6; fibroblast binding was achieved though α4β1 and α5β1 (49).

Vδ1 predominance has been reported in tumor infiltrating lymphocytes from lung (50), colon (51), renal carcinoma (52), and esophageal tumors (49). Preferential extravasation, infiltration, and retention of Vδ1 cells in esophageal tumors was attributed to higher expression and a greater variety of integrins such as CD11a/CD18, α4β1, α5β1, and αΕβ7 on Vδ1 compared to Vδ2. In particular, Vδ1 used αΕβ7 to bind SCC. Since esophageal tumors also express E-cadherin, αΕβ7 expression may provide a mechanism of lymphocyte retention in tumors (49).

Cytotoxicity

CD11a/CD18 facilitates effector-target cell conjugation (53). This interaction, integral to γδTc cytotoxicity, has been confirmed in binding assays with K562 leukemia (54), and blocking assays with Burkitt Lymphoma (55), prostate cancer (56, 57), and Daudi B cell lymphoma cells (58). We have observed significant γδTc apoptosis induced by anti-γδTCR (59) antibodies; thus, this may also occur with antibodies blocking CD18 and should be considered when designing controls and interpreting results from blocking assays using such antibodies. Activation of αβTCR changes CD11a/CD18 avidity from low to high transiently, to allow adhesion, but then also de-adhesion of T cells, promoting continued serial killing (11). If this holds true for the γδTCR, then this mechanism greatly contributes to γδTc cytotoxicity and could be therapeutically relevant.

Susceptibility to Viral Infection

In the absence of CD4, high α4 and β7 levels on IPP-expanded Vδ2 cells formed a complex with high levels of CCR5 (fivefold higher than αβTc); this inferred HIV envelope glycoprotein susceptibility resulting in CD4⁻ Vδ2 cells’ demise (60). While Vδ1 express as much α4β7 as Vδ2, they do not express CCR5, thus rendering Vδ1 immune to HIV-envelope-mediated killing (61).

Immunological Memory

CD11b (complement receptor 3, Mac-1) expression on peripheral blood T cells increased with age, leveling out later in life. γδTc expressed more CD11b than αβTc across all ages; and while not shown, CD11b was thought important for migration to spleen and liver, and to indicate antigen-specific memory T cells (62). Later studies suggested roles associated with T cell immunoregulation, proliferation, and homing (63, 64), but the significance of CD11b on human γδTc remains unknown. Increased αβTc integrin levels and adherence have been associated with memory CD4⁺ T cells (10, 65), but the only study addressing this with respect to γδTc equated Vδ1 with naïve and Vδ2 with memory cells, then compared Vδ1 to Vδ2 expression of CD11a, α4β1, and α5β1 (not CD11b), finding no correlation between adhesion/integrin levels and maturation (9). A longitudinal study following integrin expression and function during the course of γδTc maturation would be more appropriate to address this question, keeping in mind the influence of in vitro culture.

Of Rodents and Ruminants in Health and Disease…

β1 Integrins

In mice, β1 integrins play an important role in thymocyte differentiation into CD4⁺ and CD8⁺ αβTc; however, their role in γδTc development remains unknown (66).

β2 Integrins

While not found on thymocytes in adult wild-type mice, transient co-expression of CD11b and CD11d on fetal thymocytes suggests an important role for β2 integrins in early differentiation (67).

In the context of experimental autoimmune encephalitis (EAE), murine γδTc differentially expressed β2 integrins and produced more IFNγ and tumor necrosis factor α in lymph nodes, spleen, and spinal cord compared to αβTc (22). At baseline, most γδTc expressed CD11a, b, and d. Both γδTc frequency and upregulation of β2 integrins, including CD11c, were noted after EAE induction; γδTc infiltration of the central nervous system (CNS) followed that of αβTc, but was more rapid (22). Thus, β2 integrin expression on γδTc affected their trafficking into the CNS, thereby impacting EAE development kinetics (22). In a follow-up study, EAE disease severity was similar in γδTc^−/− mice reconstituted with γδTc lacking CD11a, b, or c suggesting that β2 integrins were not important for CNS trafficking; however, CD11d was still present on γδTc, pointing to this integrin’s potential role in trafficking. CD11a/CD18^−/− γδTc displayed reduced CNS retention and expansion during EAE, suggesting CD11a involvement in both retention and co-stimulation (68). While not specific to γδTc, it is interesting that CD3 expression was reduced in CD11b^−/− and CD11d^−/− mice compared to wildtype. Furthermore, CD11b and CD11d seem important for proliferation of murine T cells stimulated with PHA and Concanavalin A or superantigen, but not for their response to PMA (67). Indeed, β2 integrin expression seems concomitant with T cell expansion, in line with observations of increased CD11d expression on human γδTc expanded under higher IL-2 levels (23). In a murine spontaneous psoriasis model, reduced CD18 resulted in loss of Vγ5⁺ skin-resident γδTc and expansion of lymph node derived skin-homing Vγ4⁺ γδTc contributing to disease initiation and progression. CD18^low γδTc expressed higher IL-7Rα levels and increased IL-7-induced proliferation generating inflammatory memory CD44⁺CD27⁻ capable of IL-17 production (34). Adoptive transfer experiments confirmed that low levels of CD18 did not impair γδTc trafficking to the skin in healthy mice (34). Itgax, the gene encoding integrin CD11c, is common to γδTc and NK cells, yet, differentiates γδTc from iNKT and αβTc in the mouse (69). Murine CD11c was identified on γδTc in the blood and genital tract, most predominantly on γδTc co-expressing NK1.1. Vaginal Chlamydia infection expanded circulating CD11c⁺ γδTc (20).

The Vitronectin Receptor (VNR)

An integrin later identified as the VNR, or αvβ3, was found on murine dendritic epidermal T cell lines (DETC); its expression on splenic T cells was only observed after a minimum of 1 week of stimulation (70). VNR expression was soon further confirmed on autoreactive DETC-derived cell lines (6, 71, 72). A subset of these γδTc (Vγ1.1/Cγ4-Vδ6/Cδ1) secreted IL-4 in a VNR-dependent manner (71). In a follow-up report using a TCR^−/− hybridoma line transfected with CD3ζ fusion proteins, VNR- but not TCR-engagement by ligand was required in conjunction with CD3ζ chain signaling for IL-2 production (73). VNR recognizes the adhesive peptide sequence RGD in ECM proteins (74). While human αβTc can be induced to express VNR upon stimulation with PHA and/or PMA (75), VNR has not been found on polyclonal or clonal human γδTc (15).

α4β7 and αEβ7

High levels of α4β7 were associated with gut-tropism of murine γδTc trafficking from adult thymus to the small intestine epithelium, whereupon reaching their destination, α4β7 was subsequently downregulated, through interaction with its counterreceptor mucosal addressin cell adhesion molecule 1 (MadCAM) on the lamina propria (76). In a model of allergic reaction, IL-17⁺ γδTc expressed α4β7 that enabled their mobilization by CCL25 in inflamed tissue, which in turn modulated IL-17 levels (77). Blocking α4β7 in vivo prevented the migration of IL-17⁺ γδTc but not αβTc into mouse pleura, and also blocked transmigration of γδTc across VCAM-1- and MadCAM-1-expressing endothelium toward CCL25 or cell-free pleural washes from mice in whom an allergic reaction had been induced (77). Bovine peripheral blood-derived CD8⁺ γδTc accumulated in MAdCAM-1-expressing tissues in a dose-dependent manner. CD8⁺ γδTc expressed 1.5-fold more α4β7 than CD8^– γδTc but similar β₁ and β₂ levels. While adding CXCL12 increased MAdCAM binding of all γδTc, CCL21 activated integrins and increased CD8⁺ γδTc binding to recombinant MAdCAM1 more so than CD8⁻ γδTc. Circulating human CD8⁻ and CD8⁺ γδTc migrated similarly in response to CCL21, and expressed comparable α4β7; this species-specific discrepancy was attributed to CD8 chain usage differences in humans (αα) versus cows (αβ) (7).

Prevalence of “inflammatory” γδTc (iγδTc) co-expressing high levels of gut-homing α4β7 and αEβ7 correlated with disease severity in both spontaneous and induced murine colitis models. Cytotoxicity, cytokine production, and NK cell receptor genes were upregulated on iγδTc compared to other γδTc subsets (expressing α4β7 or αEβ7) isolated from mesenteric lymph nodes in induced colitis, suggesting profound functional relevance of integrin co-expression on these cells (78).

In αEβ7-knockout mice, γδTc IEL migration within the intraepithelial compartment was enhanced (79) and remained so when challenged with Salmonella typhimurium or Toxoplasma gondii, drastically reducing pathogen translocation and emphasizing the ability of αEβ7 to limit γδTc IEL migration and impact host defense against infection (80). In a study on suckling Lewis rats, probiotics significantly increased both CD62L-positive and negative CD4⁻CD8⁻ T cells expressing αEβ7 in mesenteric lymph nodes; in IEL, significantly increased CD62L⁻ αEβ7-expressing CD4⁻CD8⁻ cells were observed, hypothesized to result from enhanced homing and retention, respectively (81).

Concluding Remarks

T cells use classical cell biological pathways in new ways (82). Thus, understanding integrin functions on other cell types, including αβTc, suggests but does not dictate their roles on γδTc. Some roles suspected in human γδTc have been confirmed in other species, whereas interspecies variation also exists. Some integrin functions are expected and others surprising, such as HIV-induced Vδ2 demise enabled by α4β7 complexed with CCR5 (60). This review describes the tip of the iceberg with respect to integrins on γδTc; some have yet to be explored at all, and others are worthy of further study. Understanding integrin contributions to γδTc activation, proliferation, and cytotoxicity could inform better expansion protocols and improve γδTc immunotherapy for a variety of indications. We have much to learn about integrin involvement in the myriad functions of these fascinating cells.

Author Contributions

GS reviewed the literature, wrote the manuscript, and designed both the table and the figure.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

Special thanks to Dr. Gregory Dekaban, who introduced me to the exciting world of integrins, and Dr. Lynne-Marie Postovit, for continued support. Thanks to Indrani Dutta for critical reading of the manuscript.

Funding

This work has been supported by the London Regional Cancer Program, London, ON (Translational Breast Cancer Postdoctoral award) and the Cancer Research Society.

References

1. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol (1990) 8:365–400. doi:10.1146/annurev.iy.08.040190.002053

CrossRef Full Text | Google Scholar

2. Stewart M, Thiel M, Hogg N. Leukocyte integrins. Curr Opin Cell Biol (1995) 7:690–6. doi:10.1016/0955-0674(95)80111-1

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Streuli CH. Integrins as architects of cell behavior. Mol Biol Cell (2016) 27:2885–8. doi:10.1091/mbc.E15-06-0369

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Derya M, Yilmaz I, Aytekin M. The role of extracellular matrix in lung diseases. Biol Med (2014) 6:1–8. doi:10.4172/0974-8369.1000200

CrossRef Full Text | Google Scholar

5. Lub M, van Kooyk Y, Figdor CG. Ins and outs of LFA-1. Immunol Today (1995) 16:479–83. doi:10.1016/0167-5699(95)80031-X

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Halvorson MJ, Coligan JE, Sturmhofel K. The vitronectin receptor (alpha V beta 3) as an example for the role of integrins in T lymphocyte stimulation. Immunol Res (1996) 15:16–29. doi:10.1007/BF02918281

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Wilson E, Hedges JF, Butcher EC, Briskin M, Jutila MA. Bovine gamma delta T cell subsets express distinct patterns of chemokine responsiveness and adhesion molecules: a mechanism for tissue-specific gamma delta T cell subset accumulation. J Immunol (2002) 169:4970–5. doi:10.4049/jimmunol.169.9.4970

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science (1998) 279:381–4. doi:10.1126/science.279.5349.381

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Nakajima S, Roswit WT, Look DC, Holtzman MJ. A hierarchy for integrin expression and adhesiveness among T cell subsets that is linked to TCR gene usage and emphasizes V delta 1+ gamma delta T cell adherence and tissue retention. J Immunol (1995) 155:1117–31.

PubMed Abstract | Google Scholar

10. Shimizu Y, Van Seventer GA, Horgan KJ, Shaw S. Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells. Nature (1990) 345:250–3. doi:10.1038/345250a0

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature (1989) 341:619–24. doi:10.1038/341619a0

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Matsuyama T, Yamada A, Kay J, Yamada KM, Akiyama SK, Schlossman SF, et al. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med (1989) 170:1133–48. doi:10.1084/jem.170.4.1133

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Yamada A, Nikaido T, Nojima Y, Schlossman SF, Morimoto C. Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J Immunol (1991) 146:53–6.

PubMed Abstract | Google Scholar

14. Damle NK, Aruffo A. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes. Proc Natl Acad Sci U S A (1991) 88:6403–7. doi:10.1073/pnas.88.15.6403

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Wilkins J, Selin L, Stewart S, Sivananthan K, Stupack D. The interactions of gamma delta T cells with extracellular matrix: receptor expression and utilization patterns. Scand J Immunol (1992) 36:213–9. doi:10.1111/j.1365-3083.1992.tb03093.x

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Bank I, Book M, Ware R. Functional role of VLA-1 (CD49A) in adhesion, cation-dependent spreading, and activation of cultured human T lymphocytes. Cell Immunol (1994) 156:424–37. doi:10.1006/cimm.1994.1187

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Avdalovic M, Fong D, Formby B. Adhesion and costimulation of proliferative responses of human gamma delta T cells by interaction of VLA-4 and VLA-5 with fibronectin. Immunol Lett (1993) 35:101–8. doi:10.1016/0165-2478(93)90077-F

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev (1999) 10:27–39. doi:10.1016/S1359-6101(98)00024-0

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human gammadelta T Cells. Science (2005) 309:264–8. doi:10.1126/science.1110267

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Qualai J, Li LX, Cantero J, Tarrats A, Fernández MA, Sumoy L, et al. Expression of CD11c is associated with unconventional activated T cell subsets with high migratory potential. PLoS One (2016) 11:e0154253. doi:10.1371/journal.pone.0154253

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Van der Vieren M, Le Trong H, Wood CL, Moore PF, St John T, Staunton DE, et al. A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity (1995) 3:683–90. doi:10.1016/1074-7613(95)90058-6

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Smith SS, Barnum SR. Differential expression of beta 2-integrins and cytokine production between gammadelta and alphabeta T cells in experimental autoimmune encephalomyelitis. J Leukoc Biol (2008) 83:71–9. doi:10.1189/jlb.0407263

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Siegers GM, Barreira CR, Postovit LM, Dekaban GA. CD11d beta2 integrin expression on human NK, B, and gammadelta T cells. J Leukoc Biol (2017) 101:1029–35. doi:10.1189/jlb.3AB0716-326RR

CrossRef Full Text | Google Scholar

24. Van der Vieren M, Crowe DT, Hoekstra D, Vazeux R, Hoffman PA, Grayson MH, et al. The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. J Immunol (1999) 163:1984–90.

PubMed Abstract | Google Scholar

25. Hernandez-Caselles T, Rubio G, Campanero MR, del Pozo MA, Muro M, Sanchez-Madrid F, et al. ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes. Eur J Immunol (1993) 23:2799–806. doi:10.1002/eji.1830231112

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Knudsen H, Andersen CB, Ladefoged SD. Expression of the intercellular adhesion molecule-3 (ICAM-3) in human renal tissue with relation to kidney transplants and various inflammatory diseases. APMIS (1995) 103:593–6. doi:10.1111/j.1699-0463.1995.tb01411.x

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Costantini C, Calzetti F, Perbellini O, Micheletti A, Scarponi C, Lonardi S, et al. Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3. Blood (2011) 117:1677–86. doi:10.1182/blood-2010-06-287243

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Litmathe J, Boeken U, Bohlen G, Gursoy D, Sucker C, Feindt P. Systemic inflammatory response syndrome after extracorporeal circulation: a predictive algorithm for the patient at risk. Hellenic J Cardiol (2011) 52:493–500.

PubMed Abstract | Google Scholar

29. Mohagheghpour N, Bermudez LE, Khajavi S, Rivas A. The VLA-4/VCAM-1 molecules participate in gamma delta cell interaction with endothelial cells. Cell Immunol (1992) 143:170–82. doi:10.1016/0008-8749(92)90014-G

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Galea P, Brezinschek R, Lipsky PE, Oppenheimer-Marks N. Phenotypic characterization of CD4-/alpha beta TCR+ and gamma delta TCR+ T cells with a transendothelial migratory capacity. J Immunol (1994) 153:529–42.

PubMed Abstract | Google Scholar

31. Brennan FM, Londei M, Jackson AM, Hercend T, Brenner MB, Maini RN, et al. T cells expressing gamma delta chain receptors in rheumatoid arthritis. J Autoimmun (1988) 1:319–26. doi:10.1016/0896-8411(88)90002-9

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Meliconi R, Pitzalis C, Kingsley GH, Panayi GS. Gamma/delta T cells and their subpopulations in blood and synovial fluid from rheumatoid arthritis and spondyloarthritis. Clin Immunol Immunopathol (1991) 59:165–72. doi:10.1016/0090-1229(91)90090-W

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Qaqish A, Huang D, Chen CY, Zhang Z, Wang R, Li S, et al. Adoptive transfer of phosphoantigen-specific gammadelta T cell subset attenuates Mycobacterium tuberculosis infection in nonhuman primates. J Immunol (2017) 198:4753–63. doi:10.4049/jimmunol.1602019

CrossRef Full Text | Google Scholar

34. Gatzka M, Hainzl A, Peters T, Singh K, Tasdogan A, Wlaschek M, et al. Reduction of CD18 promotes expansion of inflammatory gammadelta T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis. J Immunol (2013) 191(11):5477–88. doi:10.4049/jimmunol.1300976

CrossRef Full Text | Google Scholar

35. Deusch K, Lüling F, Reich K, Classen M, Wagner H, Pfeffer K. A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol (1991) 21:1053–9. doi:10.1002/eji.1830210429

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Sioud M, Kjeldsen-Kragh J, Quayle A, Kalvenes C, Waalen K, Førre O, et al. The V delta gene usage by freshly isolated T lymphocytes from synovial fluids in rheumatoid synovitis: a preliminary report. Scand J Immunol (1990) 31:415–21. doi:10.1111/j.1365-3083.1990.tb02787.x

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Farstad IN, Halstensen TS, Lien B, Kilshaw PJ, Lazarovits AI, Brandtzaeg P. Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology (1996) 89:227–37. doi:10.1046/j.1365-2567.1996.d01-727.x

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Higgins JM, Mandlebrot DA, Shaw SK, Russell GJ, Murphy EA, Chen YT, et al. Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin. J Cell Biol (1998) 140:197–210. doi:10.1083/jcb.140.1.197

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Hardenberg JB, Braun A, Schon MP. A Yin and Yang in epithelial immunology: the roles of the alphaE(CD103)beta7 integrin in T cells. J Invest Dermatol (2018) 138:23–31. doi:10.1016/j.jid.2017.05.026

CrossRef Full Text | Google Scholar

40. Peters C, Hasler R, Wesch D, Kabelitz D. Human Vdelta2 T cells are a major source of interleukin-9. Proc Natl Acad Sci U S A (2016) 113:12520–5. doi:10.1073/pnas.1607136113

CrossRef Full Text | Google Scholar

41. Campbell AM, Chanez P, Vignola AM, Bousquet J, Couret I, Michel FB, et al. Functional characteristics of bronchial epithelium obtained by brushing from asthmatic and normal subjects. Am Rev Respir Dis (1993) 147:529–34. doi:10.1164/ajrccm/147.3.529

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Chan BM, Wong JG, Rao A, Hemler ME. T cell receptor-dependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix. J Immunol (1991) 147:398–404.

PubMed Abstract | Google Scholar

43. Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus (1992) 1:111–7. doi:10.1177/096120339200100209

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Saltini C, Hemler ME, Crystal RG. T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. Clin Immunol Immunopathol (1988) 46:221–33. doi:10.1016/0090-1229(88)90185-7

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Choy MY, Richman PI, Horton MA, MacDonald TT. Expression of the VLA family of integrins in human intestine. J Pathol (1990) 160:35–40. doi:10.1002/path.1711600109

CrossRef Full Text | Google Scholar

46. Konter U, Kellner I, Hoffmeister B, Sterry W. Induction and upregulation of adhesion receptors in oral and dermal lichen planus. J Oral Pathol Med (1990) 19:459–63. doi:10.1111/j.1600-0714.1990.tb00787.x

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Hermann GG, Geertsen PF, von der Maase H, Steven K, Andersen C, Hald T, et al. Recombinant interleukin-2 and lymphokine-activated killer cell treatment of advanced bladder cancer: clinical results and immunological effects. Cancer Res (1992) 52:726–33.

PubMed Abstract | Google Scholar

48. Hemler ME. Adhesive protein receptors on hematopoietic cells. Immunol Today (1988) 9:109–13. doi:10.1016/0167-5699(88)91280-7

CrossRef Full Text | Google Scholar

49. Thomas ML, Badwe RA, Deshpande RK, Samant UC, Chiplunkar SV. Role of adhesion molecules in recruitment of Vdelta1 T cells from the peripheral blood to the tumor tissue of esophageal cancer patients. Cancer Immunol Immunother (2001) 50:218–25. doi:10.1007/s002620100190

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Zocchi MR, Ferrarini M, Rugarli C. Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas. Eur J Immunol (1990) 20:2685–9. doi:10.1002/eji.1830201224

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Maeurer MJ, Martin D, Walter W, Liu K, Zitvogel L, Halusczcak K, et al. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med (1996) 183:1681–96. doi:10.1084/jem.183.4.1681

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Choudhary A, Davodeau F, Moreau A, Peyrat MA, Bonneville M, Jotereau F. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma. J Immunol (1995) 154:3932–40.

PubMed Abstract | Google Scholar

53. Springer TA. Adhesion receptors of the immune system. Nature (1990) 346:425–34. doi:10.1038/346425a0

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Arancia G, Malorni W, Iosi F, Zarcone D, Cerruti G, Favre A, et al. Morphological features of cloned lymphocytes expressing gamma/delta T cell receptors. Eur J Immunol (1991) 21:173–8. doi:10.1002/eji.1830210126

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Nelson EL, Kim HT, Mar ND, Goralski TJ, McIntyre BW, Clayberger C, et al. Novel tumor-associated accessory molecules involved in the gamma/delta cytotoxic T-lymphocyte-Burkitt’s lymphoma interaction. Cancer (1995) 75:886–93. doi:10.1002/1097-0142(19950201)75:3<886::AID-CNCR2820750321>3.0.CO;2-G

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Liu Z, Guo BL, Gehrs BC, Nan L, Lopez RD. Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. J Urol (2005) 173:1552–6. doi:10.1097/01.ju.0000154355.45816.0b

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Siegers GM, Ribot EJ, Keating A, Foster PJ. Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI. Cancer Immunol Immunother (2013) 62:571–83. doi:10.1007/s00262-012-1353-y

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Wang P, Malkovsky M. Different roles of the CD2 and LFA-1 T-cell co-receptors for regulating cytotoxic, proliferative, and cytokine responses of human V gamma 9/V delta 2 T cells. Mol Med (2000) 6:196–207.

PubMed Abstract | Google Scholar

59. Dutta I, Postovit LM, Siegers GM. Apoptosis induced via gamma delta T cell antigen receptor “blocking” antibodies: a cautionary tale. Front Immunol (2017) 8:776. doi:10.3389/fimmu.2017.00776

CrossRef Full Text | Google Scholar

60. Li H, Pauza CD. HIV envelope-mediated, CCR5/alpha4beta7-dependent killing of CD4-negative gammadelta T cells which are lost during progression to AIDS. Blood (2011) 118:5824–31. doi:10.1182/blood-2011-05-356535

CrossRef Full Text | Google Scholar

61. Li H, Pauza CD. The alpha4beta7 integrin binds HIV envelope but does not mediate bystander killing of gammadelta T cells. Blood (2012) 120:698–9. doi:10.1182/blood-2012-03-420117

CrossRef Full Text | Google Scholar

62. Hoshino T, Yamada A, Honda J, Imai Y, Nakao M, Inoue M, et al. Tissue-specific distribution and age-dependent increase of human CD11b+ T cells. J Immunol (1993) 151:2237–46.

PubMed Abstract | Google Scholar

63. Wagner C, Hänsch GM, Stegmaier S, Denefleh B, Hug F, Schoels M. The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function. Eur J Immunol (2001) 31:1173–80. doi:10.1002/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Nielsen HV, Christensen JP, Andersson EC, Marker O, Thomsen AR. Expression of type 3 complement receptor on activated CD8+ T cells facilitates homing to inflammatory sites. J Immunol (1994) 153:2021–8.

PubMed Abstract | Google Scholar

65. Shimizu Y, Newman W, Gopal TV, Horgan KJ, Graber N, Beall LD, et al. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol (1991) 113:1203–12. doi:10.1083/jcb.113.5.1203

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Schmeissner PJ, Xie H, Smilenov LB, Shu F, Marcantonio EE. Integrin functions play a key role in the differentiation of thymocytes in vivo. J Immunol (2001) 167:3715–24. doi:10.4049/jimmunol.167.7.3715

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Wu H, Rodgers JR, Perrard XY, Perrard JL, Prince JE, Abe Y, et al. Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes. J Immunol (2004) 173:297–306. doi:10.4049/jimmunol.173.1.297

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Wohler JE, Smith SS, Zinn KR, Bullard DC, Barnum SR. Gammadelta T cells in EAE: early trafficking events and cytokine requirements. Eur J Immunol (2009) 39:1516–26. doi:10.1002/eji.200839176

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Bezman NA, Kim CC, Sun JC, Min-Oo G, Hendricks DW, Kamimura Y, et al. Molecular definition of the identity and activation of natural killer cells. Nat Immunol (2012) 13:1000–9. doi:10.1038/ni.2395

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Maxfield SR, Moulder K, Koning F, Elbe A, Stingl G, Coligan JE, et al. Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies. J Exp Med (1989) 169:2173–90. doi:10.1084/jem.169.6.2173

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Roberts K, Yokoyama WM, Kehn PJ, Shevach EM. The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells. J Exp Med (1991) 173:231–40. doi:10.1084/jem.173.1.231

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Wilde DB, Roberts K, Sturmhöfel K, Kikuchi G, Coligan JE, Shevach EM. Mouse autoreactive gamma/delta T cells. I. Functional properties of autoreactive T cell hybridomas. Eur J Immunol (1992) 22:483–9. doi:10.1002/eji.1830220229

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Sturmhofel K, Brando C, Martinon F, Shevach EM, Coligan JE. Antigen-independent, integrin-mediated T cell activation. J Immunol (1995) 154:2104–11.

PubMed Abstract | Google Scholar

74. Ruoslahti E, Pierschbacher MD. Arg-Gly-Asp: a versatile cell recognition signal. Cell (1986) 44:517–8. doi:10.1016/0092-8674(86)90259-X

CrossRef Full Text | Google Scholar

75. Huang S, Endo RI, Nemerow GR. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol (1995) 69:2257–63.

PubMed Abstract | Google Scholar

76. Guy-Grand D, Vassalli P, Eberl G, Pereira P, Burlen-Defranoux O, Lemaitre F, et al. Origin, trafficking, and intraepithelial fate of gut-tropic T cells. J Exp Med (2013) 210:1839–54. doi:10.1084/jem.20122588

PubMed Abstract | CrossRef Full Text | Google Scholar

77. Costa MF, Bornstein VU, Candéa AL, Henriques-Pons A, Henriques MG, Penido C. CCL25 induces alpha(4)beta(7) integrin-dependent migration of IL-17(+) gammadelta T lymphocytes during an allergic reaction. Eur J Immunol (2012) 42:1250–60. doi:10.1002/eji.201142021

CrossRef Full Text | Google Scholar

78. Do JS, Kim S, Keslar K, Jang E, Huang E, Fairchild RL, et al. γδ T cells coexpressing gut homing alpha4beta7 and alphaE integrins define a novel subset promoting intestinal inflammation. J Immunol (2017) 198:908–15. doi:10.4049/jimmunol.1601060

CrossRef Full Text | Google Scholar

79. Edelblum KL, Shen L, Weber CR, Marchiando AM, Clay BS, Wang Y, et al. Dynamic migration of gammadelta intraepithelial lymphocytes requires occludin. Proc Natl Acad Sci U S A (2012) 109:7097–102. doi:10.1073/pnas.1112519109

CrossRef Full Text | Google Scholar

80. Edelblum KL, Singh G, Odenwald MA, Lingaraju A, El Bissati K, McLeod R, et al. γδ Intraepithelial lymphocyte migration limits transepithelial pathogen invasion and systemic disease in mice. Gastroenterology (2015) 148:1417–26. doi:10.1053/j.gastro.2015.02.053

CrossRef Full Text | Google Scholar

81. Rigo-Adrover MD, Franch A, Castell M, Perez-Cano FJ. Preclinical immunomodulation by the probiotic Bifidobacterium breve M-16V in early life. PLoS One (2016) 11:e0166082. doi:10.1371/journal.pone.0166082

PubMed Abstract | CrossRef Full Text | Google Scholar

82. Dustin ML. T-cells play the classics with a different spin. Mol Biol Cell (2014) 25:1699–703. doi:10.1091/mbc.E13-11-0636

PubMed Abstract | CrossRef Full Text | Google Scholar